Down syndrome and dementia: A randomized, controlled trial of antioxidant supplementation
暂无分享,去创建一个
Vinh Q Nguyen | D. Gillen | E. Head | I. Lott | E. Doran | A. Tournay
[1] J. Rusted,et al. Vitamin E for Alzheimer's dementia and mild cognitive impairment. , 2012, The Cochrane database of systematic reviews.
[2] Luca Tiano,et al. Effect of Coenzyme Q10 in mitigating oxidative DNA damage in Down syndrome patients, a double blind randomized controlled trial , 2011, Neurobiology of Aging.
[3] C. Cotman,et al. Synergistic Effects of Long-Term Antioxidant Diet and Behavioral Enrichment on β-Amyloid Load and Non-Amyloidogenic Processing in Aged Canines , 2010, The Journal of Neuroscience.
[4] Hyoung-Gon Lee,et al. Antioxidant approaches for the treatment of Alzheimer’s disease , 2010, Expert Review of Neurotherapeutics.
[5] C. Cotman,et al. Systemic mitochondrial dysfunction and the etiology of Alzheimer's disease and down syndrome dementia. , 2010, Journal of Alzheimer's disease : JAD.
[6] Mara Dierssen,et al. Cognitive deficits and associated neurological complications in individuals with Down's syndrome , 2010, The Lancet Neurology.
[7] K. Yamakawa,et al. Enlarged brain ventricles and impaired neurogenesis in the Ts1Cje and Ts2Cje mouse models of Down syndrome. , 2010, Cerebral cortex.
[8] B. Vellas,et al. Predictive factors of discontinuation and switch of cholinesterase inhibitors in community-dwelling patients with Alzheimer’s disease , 2010, CNS drugs.
[9] R. Petersen,et al. NIA-Funded Alzheimer Centers Are More Efficient than Commercial Clinical Recruitment Sites for Conducting Secondary Prevention Trials of Dementia , 2010, Alzheimer disease and associated disorders.
[10] K. Gardiner. Molecular basis of pharmacotherapies for cognition in Down syndrome. , 2010, Trends in pharmacological sciences.
[11] M. Rethoré,et al. Effect of Leucovorin (Folinic Acid) on the Developmental Quotient of Children with Down's Syndrome (Trisomy 21) and Influence of Thyroid Status , 2010, PloS one.
[12] A case for cautious optimism , 2010, Nature Neuroscience.
[13] Donna K Slonim,et al. Functional genomic analysis of amniotic fluid cell-free mRNA suggests that oxidative stress is significant in Down syndrome fetuses , 2009, Proceedings of the National Academy of Sciences.
[14] D. Schade,et al. The response of gamma vitamin E to varying dosages of alpha vitamin E plus vitamin C. , 2009, Metabolism: clinical and experimental.
[15] A. Granholm,et al. Cholinergic degeneration and memory loss delayed by vitamin E in a Down syndrome mouse model , 2009, Experimental Neurology.
[16] D. Praticò,et al. Oxidative stress and cognitive ability in adults with Down syndrome , 2009, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[17] G. Perry,et al. Chronic antioxidant therapy reduces oxidative stress in a mouse model of Alzheimer's disease , 2009, Free radical research.
[18] A. Dalton. The Dyspraxia Scale for adults with Down syndrome , 2009 .
[19] F. Pallardó,et al. Vitamin E paradox in Alzheimer's disease: it does not prevent loss of cognition and may even be detrimental. , 2009, Journal of Alzheimer's disease : JAD.
[20] Elizabeth Head,et al. Strategies for improving cognition with aging: insights from a longitudinal study of antioxidant and behavioral enrichment in canines , 2009, AGE.
[21] P. Whitaker-Azmitia,et al. Vitamin E increases S100B‐mediated microglial activation in an S100B‐overexpressing mouse model of pathological aging , 2008, Glia.
[22] Ricardo Aurino Pinho,et al. The exercise redox paradigm in the Down’s syndrome: improvements in motor function and increases in blood oxidative status in young adults , 2008, Journal of Neural Transmission.
[23] M. Altamirano-Lozano,et al. High Dosage of Ascorbic Acid and Alpha-Tocopherol Is Not Useful for Diminishing Oxidative Stress and DNA Damage in Healthy Elderly Adults , 2008, Annals of Nutrition and Metabolism.
[24] S. Leonard,et al. Gamma-tocopherol supplementation alone and in combination with alpha-tocopherol alters biomarkers of oxidative stress and inflammation in subjects with metabolic syndrome. , 2008, Free radical biology & medicine.
[25] W. Henley,et al. Supplementation with antioxidants and folinic acid for children with Down’s syndrome: randomised controlled trial , 2008, BMJ : British Medical Journal.
[26] P. Crane,et al. Antioxidant Vitamin Supplement Use and Risk of Dementia or Alzheimer's Disease in Older Adults , 2008, Journal of the American Geriatrics Society.
[27] Carl W. Cotman,et al. Proteomic identification of brain proteins in the canine model of human aging following a long-term treatment with antioxidants and a program of behavioral enrichment: Relevance to Alzheimer's disease , 2008, Neurobiology of Aging.
[28] G. Fiskum,et al. Mitochondrial dysfunction in mouse trisomy 16 brain , 2008, Brain Research.
[29] R. Bartesaghi,et al. RESEARCH ARTICLE: Neurogenesis Impairment and Increased Cell Death Reduce Total Neuron Number in the Hippocampal Region of Fetuses with Down Syndrome , 2007, Brain pathology.
[30] Elizabeth Head,et al. The canine (dog) model of human aging and disease: dietary, environmental and immunotherapy approaches. , 2008, Journal of Alzheimer's disease : JAD.
[31] N. Tabet,et al. Vitamin E for Alzheimer's disease and mild cognitive impairment. , 2008, The Cochrane database of systematic reviews.
[32] M. Schapiro,et al. Coenzyme Q10 (ubiquinol-10) supplementation improves oxidative imbalance in children with trisomy 21. , 2007, Pediatric neurology.
[33] A. Hassiotis,et al. Prevalence of dementia in intellectual disability using different diagnostic criteria. , 2007, The British journal of psychiatry : the journal of mental science.
[34] A. Cossarizza,et al. Mitochondrial alterations and tendency to apoptosis in peripheral blood cells from children with Down syndrome , 2007, FEBS letters.
[35] G. Münch,et al. α-Lipoic acid as a new treatment option for Alzheimer’s disease — a 48 months follow-up analysis , 2007 .
[36] I. Lott,et al. Alzheimer's disease in Down syndrome: neurobiology and risk. , 2007, Mental retardation and developmental disabilities research reviews.
[37] G. Münch,et al. Alpha-lipoic acid as a new treatment option for Alzheimer's disease--a 48 months follow-up analysis. , 2007, Journal of neural transmission. Supplementum.
[38] Nancy Cook,et al. A randomized trial of vitamin E supplementation and cognitive function in women. , 2006, Archives of internal medicine.
[39] P. Eikelenboom,et al. Dementia and mortality in persons with Down's syndrome. , 2006, Journal of intellectual disability research : JIDR.
[40] D. Allan Butterfield,et al. Redox proteomics identification of oxidatively modified hippocampal proteins in mild cognitive impairment: Insights into the development of Alzheimer's disease , 2006, Neurobiology of Disease.
[41] T. Montine,et al. Faster plasma vitamin E disappearance in smokers is normalized by vitamin C supplementation. , 2006, Free radical biology & medicine.
[42] W. Markesbery,et al. Increased oxidative damage in nuclear and mitochondrial DNA in mild cognitive impairment , 2006, Journal of neurochemistry.
[43] J. Hanlon,et al. Dementia and Alzheimer's Disease in Community-Dwelling Elders Taking Vitamin C and/or Vitamin E , 2005, The Annals of pharmacotherapy.
[44] T. Shea,et al. Folate, vitamin E, and acetyl-l-carnitine provide synergistic protection against oxidative stress resulting from exposure of human neuroblastoma cells to amyloid-beta , 2005, Brain Research.
[45] D. Patel,et al. Complementary and alternative medicine in developmental disabilities , 2005, Indian journal of pediatrics.
[46] W. Markesbery,et al. Ribosome Dysfunction Is an Early Event in Alzheimer's Disease , 2005, The Journal of Neuroscience.
[47] D. Bennett,et al. Vitamin E and donepezil for the treatment of mild cognitive impairment. , 2005, The New England journal of medicine.
[48] W. Tsai,et al. Assessment of Aging Individuals with Down Syndrome in Clinical Trials: Results of Baseline Measures , 2005 .
[49] C. Maxwell,et al. Supplemental Use of Antioxidant Vitamins and Subsequent Risk of Cognitive Decline and Dementia , 2005, Dementia and Geriatric Cognitive Disorders.
[50] E. Wolvetang,et al. ets-2 Promotes the Activation of a Mitochondrial Death Pathway in Down's Syndrome Neurons , 2005, The Journal of Neuroscience.
[51] C. Cotman,et al. Learning ability in aged beagle dogs is preserved by behavioral enrichment and dietary fortification: a two-year longitudinal study , 2004, Neurobiology of Aging.
[52] R. Stocker,et al. Vitamin E in human low-density lipoprotein , 2005 .
[53] K. Yaffe,et al. Impact of antioxidants, zinc, and copper on cognition in the elderly , 2004, Neurology.
[54] P. Mecocci,et al. Plasma Antioxidant Status, Immunoglobulin G Oxidation and Lipid Peroxidation in Demented Patients: Relevance to Alzheimer Disease and Vascular Dementia , 2004, Dementia and Geriatric Cognitive Disorders.
[55] S. S. Levinson,et al. Vitamins in human arteriosclerosis with emphasis on vitamin C and vitamin E. , 2004, Clinica chimica acta; international journal of clinical chemistry.
[56] D. Tappa,et al. Learning ability in aged beagle dogs is preserved by behavioral enrichment and dietary fortification : a two-year longitudinal study , 2004 .
[57] L. Appel,et al. Supplementation of Diets with α-Tocopherol Reduces Serum Concentrations of γ- and δ-Tocopherol in Humans , 2003 .
[58] R. Mayeux,et al. Antioxidant vitamin intake and risk of Alzheimer disease. , 2003, Archives of neurology.
[59] L. Appel,et al. Supplementation of diets with alpha-tocopherol reduces serum concentrations of gamma- and delta-tocopherol in humans. , 2003, The Journal of nutrition.
[60] C. Cotman,et al. β-Amyloid deposition and neurofibrillary tangle association with caspase activation in Down syndrome , 2002, Neuroscience Letters.
[61] C. Cotman,et al. Brain aging in the canine: a diet enriched in antioxidants reduces cognitive dysfunction , 2002, Neurobiology of Aging.
[62] Denis A. Evans,et al. Vitamin E and cognitive decline in older persons. , 2002, Archives of neurology.
[63] A. Hofman,et al. Dietary Intake of Antioxidants and Risk of Alzheimer Disease , 2002 .
[64] B. Lawlor,et al. Dementia in people with Down's syndrome , 2001, International journal of geriatric psychiatry.
[65] A. Reiss,et al. Neuroanatomy of Down's syndrome: a high-resolution MRI study. , 2001, The American journal of psychiatry.
[66] W. Markesbery,et al. Oxidative Alterations in Alzheimer's Disease , 1999, Brain pathology.
[67] J. Andersen,et al. Stress, Aging, and Neurodegenerative Disorders: Molecular Mechanisms a , 1998, Annals of the New York Academy of Sciences.
[68] M. Smith,et al. Early glycoxidation damage in brains from Down's syndrome. , 1998, Biochemical and biophysical research communications.
[69] P Woodbury,et al. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study. , 1997, The New England journal of medicine.
[70] R. Stocker,et al. Requirement for, promotion, or inhibition by alpha-tocopherol of radical-induced initiation of plasma lipoprotein lipid peroxidation. , 1997, Free radical biology & medicine.
[71] C. Goetz,et al. Alpha-tocopherol in the ventricular cerebrospinal fluid of Parkinson's disease patients , 1996, Neurology.
[72] H. Evenhuis,et al. Further evaluation of the Dementia Questionnaire for Persons with Mental Retardation (DMR). , 1996, Journal of intellectual disability research : JIDR.
[73] R. Bucks,et al. Assessment of activities of daily living in dementia: development of the Bristol Activities of Daily Living Scale. , 1996, Age and ageing.
[74] R. Dean,et al. Human atherosclerotic plaque contains both oxidized lipids and relatively large amounts of alpha-tocopherol and ascorbate. , 1995, Arteriosclerosis, thrombosis, and vascular biology.
[75] J. Cleary,et al. Prevention of Tocopherol-mediated Peroxidation in Ubiquinol-10-free Human Low Density Lipoprotein (*) , 1995, The Journal of Biological Chemistry.
[76] N. Driesen,et al. Selective neuroanatornic abnormalities in Down's syndrome and their cognitive correlates , 1995, Neurology.
[77] F. Boller,et al. Severe impairment battery. A neuropsychological test for severely demented patients. , 1994, Archives of neurology.
[78] H. Evenhuis,et al. Evaluation of a screening instrument for dementia in ageing mentally retarded persons. , 2008, Journal of intellectual disability research : JIDR.
[79] R. Stocker,et al. Vitamin E in human low-density lipoprotein. When and how this antioxidant becomes a pro-oxidant. , 1992, The Biochemical journal.
[80] B. Frei. Ascorbic acid protects lipids in human plasma and low-density lipoprotein against oxidative damage. , 1991, The American journal of clinical nutrition.
[81] E. Niki,et al. Action of ascorbic acid as a scavenger of active and stable oxygen radicals. , 1991, The American journal of clinical nutrition.
[82] R. Bonfanti,et al. Simultaneous determination of retinol, tocopherols, carotenes and lycopene in plasma by means of high-performance liquid chromatography on reversed phase. , 1991, International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition.
[83] G. Bartosz,et al. Down's syndrome: a pathology involving the lack of balance of reactive oxygen species. , 1988, Free radical biology & medicine.
[84] S. Zeger,et al. Longitudinal data analysis using generalized linear models , 1986 .
[85] J. Weiter,et al. Oral α-Tocopherol Supplements Decrease Plasma γ-Tocopherol Levels in Humans , 1985 .
[86] J. Weiter,et al. Oral alpha-tocopherol supplements decrease plasma gamma-tocopherol levels in humans. , 1985, The Journal of nutrition.
[87] S. Sparrow,et al. The behavior inventory for rating development (BIRD): assessments of reliability and factorial validity. , 1984, Applied research in mental retardation.
[88] K. Kojima. Proceedings of the fifth Berkeley symposium on mathematical statistics and probability. , 1969 .
[89] H. L. Le Roy,et al. Proceedings of the Fifth Berkeley Symposium on Mathematical Statistics and Probability; Vol. IV , 1969 .
[90] P. J. Huber. The behavior of maximum likelihood estimates under nonstandard conditions , 1967 .